National Health Financials
| GEGR Stock | USD 0.02 0 15.00% |
National |
Understanding current and past National Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of National Health's financial statements are interrelated, with each one affecting the others. For example, an increase in National Health's assets may result in an increase in income on the income statement.
National Health Stock Summary
iWeb Corporation operates as a medical or healthcare industry business incubator. Among the businesses it has nurtured are Radiology.com, an Internet-based radiology services and systems company, and WebMRI.com, an MRI systems design and OEM company. iWeb Corporation was founded in 1995 and is based in Los Angeles, California. GAENSEL ENERGY operates under Conglomerates classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US36255Q1085 |
| Business Address | 2034 Cotner, Los |
| Sector | Industrials |
| Industry | Conglomerates |
| Benchmark | Dow Jones Industrial |
| Website | gegrgroup.com |
| Phone | 310 914 4587 |
| Currency | USD - US Dollar |
National Health Key Financial Ratios
There are many critical financial ratios that National Health's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that National Health Scan reports annually and quarterly.National Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining National Health's current stock value. Our valuation model uses many indicators to compare National Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across National Health competition to find correlations between indicators driving National Health's intrinsic value. More Info.National Health Scan is one of the top stocks in net income category among its peers. It also is one of the top stocks in cash flow from operations category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the National Health's earnings, one of the primary drivers of an investment's value.National Health Scan Systematic Risk
National Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. National Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on National Health Scan correlated with the market. If Beta is less than 0 National Health generally moves in the opposite direction as compared to the market. If National Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one National Health Scan is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of National Health is generally in the same direction as the market. If Beta > 1 National Health moves generally in the same direction as, but more than the movement of the benchmark.
National Health December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of National Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of National Health Scan. We use our internally-developed statistical techniques to arrive at the intrinsic value of National Health Scan based on widely used predictive technical indicators. In general, we focus on analyzing National Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build National Health's daily price indicators and compare them against related drivers.
| Downside Deviation | 22.07 | |||
| Information Ratio | 0.1097 | |||
| Maximum Drawdown | 151.52 | |||
| Value At Risk | (28.00) | |||
| Potential Upside | 38.89 |
Additional Tools for National Pink Sheet Analysis
When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.